comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP- 1 Receptor Agonists in Type 2 Diabetes GLP-1 receptor agonists are increasingly

Cortisone Suppresses inflammation Fast symptom relief No tissue repair Can weaken tendons with repeat use Insurance-covered BPC-157 Promotes repair + angiogenesis Slower onset (1-3 weeks) Builds new tissue Favorable safety profile Cash-pay only ($250/mo) PRP Concentrated growth factors Moderate onset (2-6 weeks) Stimulates tissue repair Uses your own blood Sometimes insurance-covered COST AT MOONSHOT At Moonshot Medical in Park Ridge, IL, we focus on peptide-based recovery protocols: $250/mo BPC-157 at Moonshot Medical $394/mo Wolverine Blend (BPC-157 + TB-500) 503A Sourced Licensed compounding pharmacy, pharmaceutical grade We don't currently offer PRP

The discussion around semaglutide vs tirzepatide for weight loss continues to expand among obesity specialists and endocrinologists worldwide

And what about bananas should you avoid those if you have diabetes

It is also being investigated for its role in cancer prevention and management, though these are not yet approved uses

That's meaningful without crossing into protein bar territory

5 (online ed.)